Dichos y Refranes

Descargar Atlas en PDF

Atlas PDF, página 3

Atlas: 65000000 Libros PDF

  1. COVID-19 and obesity: the 2021 atlas [PDF]

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://www.worldobesityday.org/assets/downloads/COVID-19-and-Obesity-The-2021-Atlas.pdf
  2.  
    Tipo: Documento PDF

  3. Atlas Railcar

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://www.energy.gov/sites/default/files/2020/10/f80/2020_10_ATLAS_Fact-Sheet_FINAL.pdf

  4. The Atlas of Economic Complexity: Mapping Paths to Prosperity

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://growthlab.cid.harvard.edu/files/growthlab/files/atlas_2013_part1.pdf

  5. Atlas V Launch Services User's Guide - March2010

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://www.ulalaunch.com/docs/default-source/rockets/atlasvusersguide2010.pdf

  6. RAINFALL FREQUENCY ATLAS OF THE MIDWEST

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://www.isws.illinois.edu/pubdoc/B/ISWSB-71.pdf

  7. ATLAS-CONF-2020-027.pdf

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://inspirehep.net/files/417e073545cf6491ab9b909925bf51f4

  8. Birth Defects Surveillance Atlas of Selected Congenital Anomalies

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://www.cdc.gov/ncbddd/birthdefects/surveillancemanual/resource-library/photoatlas_eng-P.pdf

  9. LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ...

     
    Tipo: Documento PDF
    16 feb 2022 ... from the Phase 3b ATLAS-2M study (NCT03299049). • The primary endpoint was the proportion of participants with plasma HIV-1 RNA ≥50 copies/mL ... LONG-ACTING CABOTEGRAVIR+RILPIVIRINE EVERY 2 MONTHS ....
    https://medinfo.gsk.com/5f95dbd7-245e-4e65-9f36-1a99e28e5bba/a1963e7b-c6e4-4f7b-baa8-c3a7de0b1c6a/a1963e7b-c6e4-4f7b-baa8-c3a7de0b1c6a_viewable_rendition__v.pdf

Libro en otros formatos:


Arriba